1 Sakura S, Kirihara Y, Muguruma T, et al.The comparative neurotoxicity of intrathecal lidocaine and bupivacaine in rats[J]. Anesth Analg, 2005;101:541-547. 2 Wang Q, Liu Y, Lei Y, et al.Shenfu injection reduces toxicity of bupivacaine in rats[J].Chin Med J (Engl), 2003;116:1382-1385. 3 熊利泽, 贺大银, 王强, 等.参附注射液对三种局麻药中 枢及心脏毒性的影响[J].临床麻醉学杂志, 2005;21:188-190. 4 王强, 徐礼鲜, 朱萧玲, 等.丙泊酚保护硫氧还蛋白系统 减轻布比卡因的PC12 细胞毒性[J].中华麻醉学杂志, 2007;27:印刷中. 5 Park CJ, Park SA, Yoon TG, et al.Bupivacaine induces apoptosis via ROS in the Schwann cell line[J].J Dent Res, 2005; 84:852-857. 6 Andoh T, Chock PB, Chiueh CC.The roles of thioredoxin in protection against oxidative stress-induced apoptosis in SH-SY5Y cells[J].J Biol Chem, 2002;277:9655-9660. 7 Zink W, Graf BM.Toxicology of local anesthetics.Clinical, therapeutic and pathological mechanisms[J].Anaesthesist, 2003;52:1102-1123. 8 Gerancher JC.Cauda equina syndrome following a single spinal administration of 5 % hyperbaric lidocaine through a 25-gauge Whitacre needle[J].Anesthesiology, 1997;87:687-689. 9 Park CJ, Park SA, Yoon TG, et al.Bupivacaine induces apoptosis via ROS in the Schwann cell line[J].J Dent Res, 2005; 84:852-857. 10 Shi B, Heavner JE.Nitric oxide modulation affects the tissue distribution and toxicity of bupivacaine[J].Pharmacol Biochem Behav, 2000;66:623-629. 11 Zink W, Graf BM, Sinner B, et al.Differential effects of bupivacaine on intracellular Ca2+ regulation:potential mechanisms of its myotoxicity[J].Anesthesiology, 2002;97:710-716. 12 Unami A, Shinohara Y, Ichikawa T, et al.Biochemical and microarray analyses of bupivacaine-induced apoptosis[J].J Toxicol Sci, 2003;28:77-94. 13 Arner ES, Holmgren A.Physiological functions of thioredoxin and thioredoxin reductase[J].Eur J Biochem, 2000;267:6102-6109. 14 Nakamura H.Thioredoxin as a key molecule in redox signaling [J].Antioxid Redox Signal, 2004;6:15-17. 15 Ferret PJ, Soum E, Negre O, et al.Protective effect of thioredoxin upon NO-mediated cell injury in THP1 monocytic human cells[J].Biochem J, 2000;346:759-765. |